Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2010
07/07/2010EP2203436A1 Pyrazine derivatives and their use as potassium channel modulators
07/07/2010EP2203426A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
07/07/2010EP2203423A1 Indoline compounds
07/07/2010EP2203422A1 Phenylpyrrolidine compounds
07/07/2010EP2203416A1 (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
07/07/2010EP2203415A1 (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
07/07/2010EP2203411A2 N-phenyl anthranilic acid derivatives and uses thereof
07/07/2010EP1940817B1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
07/07/2010EP1900811B1 Enriched central nervous system cell populations
07/07/2010EP1861380B1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
07/07/2010EP1765829B1 Tricyclic compounds and their use as mglur1 antagonists
07/07/2010EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010EP1392301B1 Prevention of addiction in pain management with gamma vinyl gaba
07/07/2010EP1334201B1 Dna expression vectors
07/07/2010CN1679709B External-applied resuscitation-reducing washing liquid for treating cephalagia and preparation thereof
07/07/2010CN101772572A Method of enhancing migration of neural precursor cells
07/07/2010CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
07/07/2010CN101772498A Heteroaryl amide analogues as p2x7 antagonists
07/07/2010CN101772497A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate
07/07/2010CN101772494A 4-pyrimidinesulfamide derivative
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101772490A Trazodone and trazodone hydrochloride in purified form
07/07/2010CN101768569A Nerve cell inducer and application thereof
07/07/2010CN101768202A Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof
07/07/2010CN101768185A Dipropofol dihydrogen pyrophosphate and salt thereof, preparation method and application thereof
07/07/2010CN101768124A Medicine crystal, preparation method and purpose thereof
07/07/2010CN101768079A Compound and medicinal application thereof
07/07/2010CN101766808A Method for obtaining series analgesic active peptides DKK and analogs thereof and application of series analgesic active peptide DKK and analogs thereof
07/07/2010CN101766801A Anti-depression Xiaoyao powder effective component and extraction method thereof
07/07/2010CN101766788A Pharmaceutical composite for treating cerebrovascular diseases
07/07/2010CN101766784A Chinese medicinal granule for treating senile dementia
07/07/2010CN101766767A Chinese medicine composition for headaches
07/07/2010CN101766754A Chinese medicine composite for treating coma and preparation method thereof
07/07/2010CN101766753A Vitality source capsule and preparation method thereof
07/07/2010CN101766746A External bee venom liniment
07/07/2010CN101766717A Composite for disintoxicating and sobering
07/07/2010CN101766716A Hangover relieving composition
07/07/2010CN101766715A Composite for disintoxicating and sobering
07/07/2010CN101766706A Medicinal combination containing borneol and musk
07/07/2010CN101766705A Medicinal combination containing borneol and musk
07/07/2010CN101766704A Medicinal combination containing borneol and musk
07/07/2010CN101766703A Medicinal combination containing borneol and musk
07/07/2010CN101766702A Medicinal combination containing borneol and musk
07/07/2010CN101766701A Medicinal combination containing musk
07/07/2010CN101766700A Medicinal combination containing musk
07/07/2010CN101766699A Medicinal combination containing musk
07/07/2010CN101766696A Brewing method of medicated wine capable of preventing senile dementia
07/07/2010CN101766694A Process for extracting total glucosides from desertliving cistanche and preparation thereof
07/07/2010CN101766693A Process for extracting total flavonoid from lotus plumule with high efficiency
07/07/2010CN101766690A Multipurpose utilization method for improving the value of schisandra chinensis medicinal material
07/07/2010CN101766686A Pharmaceutical composite for treating cerebral stroke, preparation method and application thereof
07/07/2010CN101766676A Extract of Albizia chinensis (Osbeck) Merr, preparation method, combination and purpose thereof
07/07/2010CN101766672A Composite for disintoxicating and sobering
07/07/2010CN101766662A Process for efficiently concentrating cordycepin
07/07/2010CN101766660A Preparation having function of improving memories and preparation method and application thereof
07/07/2010CN101766659A Preparation having function of improving memories and preparation method and application thereof
07/07/2010CN101766653A Method for preparing earthworm decocting pieces in one step
07/07/2010CN101766642A Application of panaxoside Rd in preparing medicament for preventing and curing Alzheimer's disease
07/07/2010CN101766637A Composite for disintoxicating and sobering
07/07/2010CN101766636A Composite for disintoxicating and sobering
07/07/2010CN101766635A Composite for disintoxicating and sobering
07/07/2010CN101766626A Blonanserin-contained oral preparation for treating schizophrenia
07/07/2010CN101766625A Application of Morphine as medicament for promoting growth of nerve cells
07/07/2010CN101766624A Application of Morphine as medicament for promoting growth of PC12 cells
07/07/2010CN101766623A Application of Morphine as antioxidant stress injury agent
07/07/2010CN101766622A Application of Morphine as medicament for protecting PC12 cells from injuries of Parkinson disease toxic substance
07/07/2010CN101766621A Application of Morphine in preparing medicaments for treating Parkinson disease
07/07/2010CN101766597A Injection preparation with levo-oxiracetam as active component
07/07/2010CN101766596A Solid preparation with dextro-oxiracetam as active component
07/07/2010CN101766595A Solid preparation with levo-oxiracetam as active component
07/07/2010CN101766587A Application of honokiol during preparing hypnotic drugs and health care products
07/07/2010CN101766580A Scopoamine butylbromide ibuprofen tablet and preparation method thereof
07/07/2010CN101766579A Duloxetine enteric-coated sustained release preparation as well as core material and preparation method thereof
07/07/2010CN101766576A Buccal tablet with fentanyl as main active component and preparation method thereof
07/07/2010CN101766575A Dropping pill with fentanyl as main active component and preparation method thereof
07/07/2010CN101766574A Preparation formulations of sodium pyruvate freeze-dried powder injection, injection and solid agent and production processes thereof
07/07/2010CN101766567A Oral liquid preparation with dextro-oxiracetam as active component
07/07/2010CN101766566A Method for preparing injection of sodium ferulate
07/07/2010CN101766565A Oral liquid preparation with levo-oxiracetam as active component
07/07/2010CN101766422A Brassica campestris L. seed health-care pillow and manufacturing method thereof
07/07/2010CN101249236B Chinese and western medicine combined preparations for curing epileptic
07/07/2010CN101214054B Health food with promoting lead-expelling function and auxiliary improving memory function
07/07/2010CN101015545B Use of phenylpropionic acid and phenyl propyl compound with oxidation resistance function for protecting liver and brain damage
07/07/2010CN101015544B Use of phenyl propyl compound with oxidation resistance function for protecting liver and brain damage
07/07/2010CN101015543B Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage
07/07/2010CN101002930B Medicine composition containing aniracetam and brain protein hydrolyte
07/06/2010USRE41425 Piperazine and piperidine compounds
07/06/2010US7750037 Antidepressant
07/06/2010US7750030 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
07/06/2010US7750028 treating epilepsy comprising administering polymorphic rufinamide's that differ with respect to their thermodynamic stability, in their physical parameters, such as the absorption pattern of infrared and raman spectrum analysis
07/06/2010US7750025 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
07/06/2010US7750024 [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid, 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one, or 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline; AMPA receptor antagonist; anticarcinogenic agents
07/06/2010US7750022 modulators of nicotinic and/or of the monoamine receptors such as 3-(Dibenzofuran-2-yloxy)-1-azabicyclo[2.2.2]octane, useful for the treatment of nervous system disorders, neurodegenerative diseases and drug abuse and dependence
07/06/2010US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof
07/06/2010US7750011 Diazabicyclic aryl derivatives and their medical use
07/06/2010US7750010 2-(2,5-Dioxo-5,6-dihydro-4H-imidazo[1,5,4-de]quinoxalin-1(2H)-yl)-N-(3-methyl-spiro[imidazolidine-4,2'-indane]-2,5-dione)acetamide, used as Calcitonin Gene-Related Peptide (CGRP), ligands useful in the treatment or prevention of headaches
07/06/2010US7749758 Human and mammalian stem cell-derived neuron survival factors
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1833